Antibodies against 4G7-derived chimeric antigen receptors

JP7672343B2Active Publication Date: 2025-05-07ALLOGENE THERAPEUTICS INC
4 Cites 0 Cited by

Patent Information

Application Number
JP2021562032
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-04-19
Filing Date
2020-04-17
Publication Date
2025-05-07
Estimated Expiration
2040-04-17
Patent Text Reader

Abstract

Provided herein are isolated antibodies that specifically bind to an anti-CD19 chimeric antigen receptor (CAR) derived from 4G7 scFv. Also provided are methods of making and using these isolated antibodies.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • CD19-specific chimeric antigen receptor and its use

    JP2016520074A

  • Polypeptide compositions comprising spacers

    US20190111080A1

  • Anti-idiotypic antibodies and related methods

    WO2018023100A2

  • Reagents for expanding cells expressing recombinant receptors

    WO2019027850A1